april new york time publish articl high
incid kidney failur among patient
subsequ increas demand hospit continu renal
replac therapi crrt articl state
covid patient icu suffer kidney failur need
emerg dialysi surg kidney failur patient lead
shortag dialysi machin hospit rais pt
base equal weight ev/ebitda
dcf p/e/g continu believ one
best-posit name current environ
freseniu nxstage two lead manufactur
crrt equip highlight increas demand prismax
prismaflex crrt system covid respons press releas
april articl state order dialysi equip
suppli among two manufactur presum
nxstage fivefold place limit
hospit could order prevent hoard interestingli hospit
short suppli crrt system turn periton
dialysi altern also leader pd therapi
share asid weve also heard
tailwind home dialysi therapi pd
sale bax crrt system book bax acut therapi
segment ex-fx model sale
ex-fx base articl view
current acut therapi forecast conserv
also see increas demand iv solut pump
certain inject drug use icu due
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
exclud one-tim item adjust
compani data secur llc estim reuter
price target
price target base equal weight ev/ebitda dcf p/e/g risk
thesi includ uncertainti pandem unexpect competit signific delay
expect weather pandem rel better mani peer see
potenti sale growth acceler margin expans continu
baxter global medic product compani focus hospit product renal compani
report sale billion ex-fx growth
